Robin Denhardt-Eriksson's Contact Details

Robin Denhardt-Eriksson's Company Details

LYO-X AG

Allschwil, Basel-Landschaft, Switzerland • 8 Employees
Research

LYO-X is a company providing strategic consulting and PK/PD modelling services dedicated to the preclinical and clinical development of biologics and cell based therapies. Our speciality are drug formats at the scientific edge: bi-specifics, antibody-drug conjugates, scFv's, nanobodies and cell based therapies. Whatever your therapeutic approach, we have the expertise in biology, pharmacology, mathematical modeling and drug development to provide tailored support for your unique program. We apply systems pharmacology for target assessment, format selection, compound design, candidate selection, design and analysis of preclinical PK/PD and GLP toxicology studies, first in human dose selection, dose / regimen finding studies and paediatric drug development. Our customers are biotechnology start-ups, pharmaceutical companies and CROs.LYO-X is part if the iBx Network. The iBx Network provides integrated services in toxicology, pharmacology, preclinical and clinical development in combination with modelling and simulation. For more information see www.lyo-x.com